# Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine

> **NCT06146088** · PHASE4 · RECRUITING · sponsor: **Institute of Medical Biology, Chinese Academy of Medical Sciences** · enrollment: 1500 (estimated)

## Conditions studied

- Hand, Foot and Mouth Disease

## Interventions

- **BIOLOGICAL:** EV71 Vaccine

## Key facts

- **NCT ID:** NCT06146088
- **Lead sponsor:** Institute of Medical Biology, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-25
- **Primary completion:** 2024-03-31
- **Final completion:** 2026-07-15
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2024-01-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06146088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06146088, "Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06146088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*